[Dissolution and pharmacokinetic studies on controlled release indomethacin suppository]. 1987

Y H Zhang, and G H Liu, and Q N Ping

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal

Related Publications

Y H Zhang, and G H Liu, and Q N Ping
October 1985, The American journal of medicine,
Y H Zhang, and G H Liu, and Q N Ping
January 1984, Journal of microencapsulation,
Y H Zhang, and G H Liu, and Q N Ping
July 2003, Farmaco (Societa chimica italiana : 1989),
Y H Zhang, and G H Liu, and Q N Ping
September 1995, The Journal of pharmacy and pharmacology,
Y H Zhang, and G H Liu, and Q N Ping
January 1988, Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences,
Y H Zhang, and G H Liu, and Q N Ping
November 1997, Pharmaceutical development and technology,
Y H Zhang, and G H Liu, and Q N Ping
August 2001, Drug development and industrial pharmacy,
Y H Zhang, and G H Liu, and Q N Ping
December 1982, Archivos de farmacologia y toxicologia,
Y H Zhang, and G H Liu, and Q N Ping
March 1985, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Copied contents to your clipboard!